Kindred Biosciences Unveils Positive Results from Pilot Study of its Interleukin-4R Monoclonal Antibody Being Developed for the Treatment of Atopic Dermatitis in Dogs

Stock Information for Kindred Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.